APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bioconjugation Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bioconjugation Service Market Analysis and Forecast 2026-2032

15 April 2026218 pages

Choose your research edition.

Industry ResearchBioconjugation Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioconjugation Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Bioconjugation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioconjugation Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Bioconjugation Service Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Bioconjugation Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bioconjugation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bioconjugation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bioconjugation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bioconjugation Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bioconjugation Service include AxisPharm, CellMosaic, Bio-Synthesis, GBI, Lonza, NJ Bio, WuXi Biologics, Creative Biolabs and Biosynth, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bioconjugation Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bioconjugation Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Bioconjugation Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bioconjugation Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bioconjugation Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bioconjugation Service revenue, projected growth trends, production technology, application and end-user industry.

Bioconjugation Service Segment by Company

AxisPharm

CellMosaic

Bio-Synthesis

GBI

Lonza

NJ Bio

WuXi Biologics

Creative Biolabs

Biosynth

Antibody Solutions

CheMatech

Thermo Fisher Scientific Inc

BOC Sciences

GTP Bioways

LifeSynth Solutions

iQ Biosciences

Macrocyclics

piramal pharma solutions

Bioconjugation Service Segment by Type

Protein Bioconjugation

Antibody Bioconjugation

Peptide Bioconjugation

Others

Bioconjugation Service Segment by Application

Pharmaceutical

Diagnostics

Biotechnology Research

Bioconjugation Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioconjugation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugation Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bioconjugation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bioconjugation Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bioconjugation Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bioconjugation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Protein Bioconjugation Major Player Table 3. Antibody Bioconjugation Major Player Table 4. Peptide Bioconjugation Major Player Table 5. Others Major Player Table 6. Global Bioconjugation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Major Player Table 8. Diagnostics Major Player Table 9. Biotechnology Research Major Player Table 10. Bioconjugation Service Industry Trends Table 11. Bioconjugation Service Industry Drivers Table 12. Bioconjugation Service Industry Opportunities and Challenges Table 13. Bioconjugation Service Industry Restraints Table 14. Global Bioconjugation Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Bioconjugation Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Bioconjugation Service Market Share by Region (2021-2026) Table 17. Global Bioconjugation Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Bioconjugation Service Market Share by Region (2027-2032) Table 19. Global Bioconjugation Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Bioconjugation Service Revenue Market Share by Players (2021-2026) Table 21. Global Bioconjugation Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Bioconjugation Service Key Players Headquarters & Area Served Table 23. Global Bioconjugation Service Players, Product Type & Application Table 24. Global Bioconjugation Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Bioconjugation Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Bioconjugation Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Bioconjugation Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Bioconjugation Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Bioconjugation Service Revenue Market Share by Type (2021-2026) Table 31. Global Bioconjugation Service Revenue Market Share by Type (2027-2032) Table 32. Global Bioconjugation Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Bioconjugation Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Bioconjugation Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Bioconjugation Service Revenue Market Share by Application (2021-2026) Table 36. Global Bioconjugation Service Revenue Market Share by Application (2027-2032) Table 37. AxisPharm Company Information Table 38. AxisPharm Business Overview Table 39. AxisPharm Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AxisPharm Bioconjugation Service Product Portfolio Table 41. AxisPharm Recent Development Table 42. CellMosaic Company Information Table 43. CellMosaic Business Overview Table 44. CellMosaic Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. CellMosaic Bioconjugation Service Product Portfolio Table 46. CellMosaic Recent Development Table 47. Bio-Synthesis Company Information Table 48. Bio-Synthesis Business Overview Table 49. Bio-Synthesis Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Bio-Synthesis Bioconjugation Service Product Portfolio Table 51. Bio-Synthesis Recent Development Table 52. GBI Company Information Table 53. GBI Business Overview Table 54. GBI Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. GBI Bioconjugation Service Product Portfolio Table 56. GBI Recent Development Table 57. Lonza Company Information Table 58. Lonza Business Overview Table 59. Lonza Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Lonza Bioconjugation Service Product Portfolio Table 61. Lonza Recent Development Table 62. NJ Bio Company Information Table 63. NJ Bio Business Overview Table 64. NJ Bio Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. NJ Bio Bioconjugation Service Product Portfolio Table 66. NJ Bio Recent Development Table 67. WuXi Biologics Company Information Table 68. WuXi Biologics Business Overview Table 69. WuXi Biologics Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. WuXi Biologics Bioconjugation Service Product Portfolio Table 71. WuXi Biologics Recent Development Table 72. Creative Biolabs Company Information Table 73. Creative Biolabs Business Overview Table 74. Creative Biolabs Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Creative Biolabs Bioconjugation Service Product Portfolio Table 76. Creative Biolabs Recent Development Table 77. Biosynth Company Information Table 78. Biosynth Business Overview Table 79. Biosynth Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Biosynth Bioconjugation Service Product Portfolio Table 81. Biosynth Recent Development Table 82. Antibody Solutions Company Information Table 83. Antibody Solutions Business Overview Table 84. Antibody Solutions Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Antibody Solutions Bioconjugation Service Product Portfolio Table 86. Antibody Solutions Recent Development Table 87. CheMatech Company Information Table 88. CheMatech Business Overview Table 89. CheMatech Bioconjugation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. CheMatech Bioconjugation Service Product Portfolio Table 91. CheMatech Recent Development Table 92. Thermo Fisher Scientific Inc Company Information Table 93. Thermo Fisher Scientific Inc Business Overview Table 94. Thermo Fisher Scientific Inc Bioconjugation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Thermo Fisher Scientific Inc Bioconjugation Service Product Portfolio Table 96. Thermo Fisher Scientific Inc Recent Development Table 97. BOC Sciences Company Information Table 98. BOC Sciences Business Overview Table 99. BOC Sciences Bioconjugation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. BOC Sciences Bioconjugation Service Product Portfolio Table 101. BOC Sciences Recent Development Table 102. GTP Bioways Company Information Table 103. GTP Bioways Business Overview Table 104. GTP Bioways Bioconjugation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. GTP Bioways Bioconjugation Service Product Portfolio Table 106. GTP Bioways Recent Development Table 107. LifeSynth Solutions Company Information Table 108. LifeSynth Solutions Business Overview Table 109. LifeSynth Solutions Bioconjugation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. LifeSynth Solutions Bioconjugation Service Product Portfolio Table 111. LifeSynth Solutions Recent Development Table 112. iQ Biosciences Company Information Table 113. iQ Biosciences Business Overview Table 114. iQ Biosciences Bioconjugation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. iQ Biosciences Bioconjugation Service Product Portfolio Table 116. iQ Biosciences Recent Development Table 117. Macrocyclics Company Information Table 118. Macrocyclics Business Overview Table 119. Macrocyclics Bioconjugation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Macrocyclics Bioconjugation Service Product Portfolio Table 121. Macrocyclics Recent Development Table 122. piramal pharma solutions Company Information Table 123. piramal pharma solutions Business Overview Table 124. piramal pharma solutions Bioconjugation Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. piramal pharma solutions Bioconjugation Service Product Portfolio Table 126. piramal pharma solutions Recent Development Table 127. North America Bioconjugation Service Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Bioconjugation Service Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Bioconjugation Service Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Bioconjugation Service Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Bioconjugation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Bioconjugation Service Revenue by Country (2021-2026) & (US$ Million) Table 133. North America Bioconjugation Service Revenue by Country (US$ Million) & (2027-2032) Table 134. Europe Bioconjugation Service Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Bioconjugation Service Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Bioconjugation Service Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Bioconjugation Service Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Bioconjugation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Bioconjugation Service Revenue by Country (2021-2026) & (US$ Million) Table 140. Europe Bioconjugation Service Revenue by Country (US$ Million) & (2027-2032) Table 141. China Bioconjugation Service Revenue by Type (2021-2026) & (US$ Million) Table 142. China Bioconjugation Service Revenue by Type (2027-2032) & (US$ Million) Table 143. China Bioconjugation Service Revenue by Application (2021-2026) & (US$ Million) Table 144. China Bioconjugation Service Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Bioconjugation Service Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Bioconjugation Service Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Bioconjugation Service Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Bioconjugation Service Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Bioconjugation Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Bioconjugation Service Revenue by Region (US$ Million) & (2021-2026) Table 151. Asia Bioconjugation Service Revenue by Region (US$ Million) & (2027-2032) Table 152. SAMEA Bioconjugation Service Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Bioconjugation Service Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Bioconjugation Service Revenue by Application (2021-2026) & (US$ Million) Table 155. SAMEA Bioconjugation Service Revenue by Application (2027-2032) & (US$ Million) Table 156. SAMEA Bioconjugation Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. SAMEA Bioconjugation Service Revenue by Country (2021-2026) & (US$ Million) Table 158. SAMEA Bioconjugation Service Revenue by Country (US$ Million) & (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Bioconjugation Service Image Figure 2. Global Bioconjugation Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioconjugation Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Protein Bioconjugation Image Figure 5. Antibody Bioconjugation Image Figure 6. Peptide Bioconjugation Image Figure 7. Others Image Figure 8. Global Bioconjugation Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Bioconjugation Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Image Figure 11. Diagnostics Image Figure 12. Biotechnology Research Image Figure 13. Global Bioconjugation Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Bioconjugation Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Bioconjugation Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Bioconjugation Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Bioconjugation Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Bioconjugation Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Bioconjugation Service Revenue Market Share by Type (2021-2032) Figure 21. Global Bioconjugation Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Bioconjugation Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Bioconjugation Service Revenue Market Share by Application (2021-2032) Figure 24. North America Bioconjugation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Bioconjugation Service Revenue Share by Type (2021-2032) Figure 26. North America Bioconjugation Service Revenue Share by Application (2021-2032) Figure 27. North America Bioconjugation Service Revenue Share by Country (2021-2032) Figure 28. United States Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Bioconjugation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Bioconjugation Service Revenue Share by Type (2021-2032) Figure 33. Europe Bioconjugation Service Revenue Share by Application (2021-2032) Figure 34. Europe Bioconjugation Service Revenue Share by Country (2021-2032) Figure 35. Germany Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Bioconjugation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Bioconjugation Service Revenue Share by Type (2021-2032) Figure 45. China Bioconjugation Service Revenue Share by Application (2021-2032) Figure 46. Asia Bioconjugation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Bioconjugation Service Revenue Share by Type (2021-2032) Figure 48. Asia Bioconjugation Service Revenue Share by Application (2021-2032) Figure 49. Asia Bioconjugation Service Revenue Share by Region (2021-2032) Figure 50. Japan Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Bioconjugation Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Bioconjugation Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Bioconjugation Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Bioconjugation Service Revenue Share by Country (2021-2032) Figure 60. Brazil Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Bioconjugation Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Protein Bioconjugation
  • Antibody Bioconjugation
  • Peptide Bioconjugation
  • Others
Applications
  • Pharmaceutical
  • Diagnostics
  • Biotechnology Research
Companies covered
  • AxisPharm
  • CellMosaic
  • Bio-Synthesis
  • GBI
  • Lonza
  • NJ Bio
  • WuXi Biologics
  • Creative Biolabs
  • Biosynth
  • Antibody Solutions
  • CheMatech
  • Thermo Fisher Scientific Inc
  • BOC Sciences
  • GTP Bioways
  • LifeSynth Solutions
  • iQ Biosciences
  • Macrocyclics
  • piramal pharma solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bioconjugation Service Market by Type
  3. 1.2.1 Global Bioconjugation Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Protein Bioconjugation
  5. 1.2.3 Antibody Bioconjugation
  6. 1.2.4 Peptide Bioconjugation
  7. 1.2.5 Others
  8. 1.3 Bioconjugation Service Market by Application
  9. 1.3.1 Global Bioconjugation Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical
  11. 1.3.3 Diagnostics
  12. 1.3.4 Biotechnology Research
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Bioconjugation Service Market Dynamics
  1. 2.1 Bioconjugation Service Industry Trends
  2. 2.2 Bioconjugation Service Industry Drivers
  3. 2.3 Bioconjugation Service Industry Opportunities and Challenges
  4. 2.4 Bioconjugation Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bioconjugation Service Market Perspective (2021-2032)
  2. 3.2 Global Bioconjugation Service Growth Trends by Region
  3. 3.2.1 Global Bioconjugation Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bioconjugation Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Bioconjugation Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bioconjugation Service Revenue by Players
  2. 4.1.1 Global Bioconjugation Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Bioconjugation Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bioconjugation Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bioconjugation Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bioconjugation Service Key Players Headquarters & Area Served
  7. 4.4 Global Bioconjugation Service Players, Product Type & Application
  8. 4.5 Global Bioconjugation Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bioconjugation Service Market CR5 and HHI
  11. 4.6.3 2025 Bioconjugation Service Tier 1, Tier 2, and Tier 3
5 Bioconjugation Service Market Size by Type
  1. 5.1 Global Bioconjugation Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bioconjugation Service Revenue by Type (2021-2032)
  3. 5.3 Global Bioconjugation Service Revenue Market Share by Type (2021-2032)
6 Bioconjugation Service Market Size by Application
  1. 6.1 Global Bioconjugation Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bioconjugation Service Revenue by Application (2021-2032)
  3. 6.3 Global Bioconjugation Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AxisPharm
  2. 7.1.1 AxisPharm Company Information
  3. 7.1.2 AxisPharm Business Overview
  4. 7.1.3 AxisPharm Bioconjugation Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AxisPharm Bioconjugation Service Product Portfolio
  6. 7.1.5 AxisPharm Recent Developments
  7. 7.2 CellMosaic
  8. 7.2.1 CellMosaic Company Information
  9. 7.2.2 CellMosaic Business Overview
  10. 7.2.3 CellMosaic Bioconjugation Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 CellMosaic Bioconjugation Service Product Portfolio
  12. 7.2.5 CellMosaic Recent Developments
  13. 7.3 Bio-Synthesis
  14. 7.3.1 Bio-Synthesis Company Information
  15. 7.3.2 Bio-Synthesis Business Overview
  16. 7.3.3 Bio-Synthesis Bioconjugation Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bio-Synthesis Bioconjugation Service Product Portfolio
  18. 7.3.5 Bio-Synthesis Recent Developments
  19. 7.4 GBI
  20. 7.4.1 GBI Company Information
  21. 7.4.2 GBI Business Overview
  22. 7.4.3 GBI Bioconjugation Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 GBI Bioconjugation Service Product Portfolio
  24. 7.4.5 GBI Recent Developments
  25. 7.5 Lonza
  26. 7.5.1 Lonza Company Information
  27. 7.5.2 Lonza Business Overview
  28. 7.5.3 Lonza Bioconjugation Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Lonza Bioconjugation Service Product Portfolio
  30. 7.5.5 Lonza Recent Developments
  31. 7.6 NJ Bio
  32. 7.6.1 NJ Bio Company Information
  33. 7.6.2 NJ Bio Business Overview
  34. 7.6.3 NJ Bio Bioconjugation Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 NJ Bio Bioconjugation Service Product Portfolio
  36. 7.6.5 NJ Bio Recent Developments
  37. 7.7 WuXi Biologics
  38. 7.7.1 WuXi Biologics Company Information
  39. 7.7.2 WuXi Biologics Business Overview
  40. 7.7.3 WuXi Biologics Bioconjugation Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 WuXi Biologics Bioconjugation Service Product Portfolio
  42. 7.7.5 WuXi Biologics Recent Developments
  43. 7.8 Creative Biolabs
  44. 7.8.1 Creative Biolabs Company Information
  45. 7.8.2 Creative Biolabs Business Overview
  46. 7.8.3 Creative Biolabs Bioconjugation Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Creative Biolabs Bioconjugation Service Product Portfolio
  48. 7.8.5 Creative Biolabs Recent Developments
  49. 7.9 Biosynth
  50. 7.9.1 Biosynth Company Information
  51. 7.9.2 Biosynth Business Overview
  52. 7.9.3 Biosynth Bioconjugation Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Biosynth Bioconjugation Service Product Portfolio
  54. 7.9.5 Biosynth Recent Developments
  55. 7.10 Antibody Solutions
  56. 7.10.1 Antibody Solutions Company Information
  57. 7.10.2 Antibody Solutions Business Overview
  58. 7.10.3 Antibody Solutions Bioconjugation Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Antibody Solutions Bioconjugation Service Product Portfolio
  60. 7.10.5 Antibody Solutions Recent Developments
  61. 7.11 CheMatech
  62. 7.11.1 CheMatech Company Information
  63. 7.11.2 CheMatech Business Overview
  64. 7.11.3 CheMatech Bioconjugation Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 CheMatech Bioconjugation Service Product Portfolio
  66. 7.11.5 CheMatech Recent Developments
  67. 7.12 Thermo Fisher Scientific Inc
  68. 7.12.1 Thermo Fisher Scientific Inc Company Information
  69. 7.12.2 Thermo Fisher Scientific Inc Business Overview
  70. 7.12.3 Thermo Fisher Scientific Inc Bioconjugation Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Thermo Fisher Scientific Inc Bioconjugation Service Product Portfolio
  72. 7.12.5 Thermo Fisher Scientific Inc Recent Developments
  73. 7.13 BOC Sciences
  74. 7.13.1 BOC Sciences Company Information
  75. 7.13.2 BOC Sciences Business Overview
  76. 7.13.3 BOC Sciences Bioconjugation Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 BOC Sciences Bioconjugation Service Product Portfolio
  78. 7.13.5 BOC Sciences Recent Developments
  79. 7.14 GTP Bioways
  80. 7.14.1 GTP Bioways Company Information
  81. 7.14.2 GTP Bioways Business Overview
  82. 7.14.3 GTP Bioways Bioconjugation Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 GTP Bioways Bioconjugation Service Product Portfolio
  84. 7.14.5 GTP Bioways Recent Developments
  85. 7.15 LifeSynth Solutions
  86. 7.15.1 LifeSynth Solutions Company Information
  87. 7.15.2 LifeSynth Solutions Business Overview
  88. 7.15.3 LifeSynth Solutions Bioconjugation Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 LifeSynth Solutions Bioconjugation Service Product Portfolio
  90. 7.15.5 LifeSynth Solutions Recent Developments
  91. 7.16 iQ Biosciences
  92. 7.16.1 iQ Biosciences Company Information
  93. 7.16.2 iQ Biosciences Business Overview
  94. 7.16.3 iQ Biosciences Bioconjugation Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 iQ Biosciences Bioconjugation Service Product Portfolio
  96. 7.16.5 iQ Biosciences Recent Developments
  97. 7.17 Macrocyclics
  98. 7.17.1 Macrocyclics Company Information
  99. 7.17.2 Macrocyclics Business Overview
  100. 7.17.3 Macrocyclics Bioconjugation Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Macrocyclics Bioconjugation Service Product Portfolio
  102. 7.17.5 Macrocyclics Recent Developments
  103. 7.18 piramal pharma solutions
  104. 7.18.1 piramal pharma solutions Company Information
  105. 7.18.2 piramal pharma solutions Business Overview
  106. 7.18.3 piramal pharma solutions Bioconjugation Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 piramal pharma solutions Bioconjugation Service Product Portfolio
  108. 7.18.5 piramal pharma solutions Recent Developments
8 North America
  1. 8.1 North America Bioconjugation Service Revenue (2021-2032)
  2. 8.2 North America Bioconjugation Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Bioconjugation Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Bioconjugation Service Revenue by Type (2027-2032)
  5. 8.3 North America Bioconjugation Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Bioconjugation Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Bioconjugation Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Bioconjugation Service Revenue by Application (2027-2032)
  9. 8.5 North America Bioconjugation Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Bioconjugation Service Revenue by Country
  11. 8.6.1 North America Bioconjugation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bioconjugation Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Bioconjugation Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Bioconjugation Service Revenue (2021-2032)
  2. 9.2 Europe Bioconjugation Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bioconjugation Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bioconjugation Service Revenue by Type (2027-2032)
  5. 9.3 Europe Bioconjugation Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bioconjugation Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bioconjugation Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bioconjugation Service Revenue by Application (2027-2032)
  9. 9.5 Europe Bioconjugation Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bioconjugation Service Revenue by Country
  11. 9.6.1 Europe Bioconjugation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bioconjugation Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bioconjugation Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Bioconjugation Service Revenue (2021-2032)
  2. 10.2 China Bioconjugation Service Revenue by Type (2021-2032)
  3. 10.2.1 China Bioconjugation Service Revenue by Type (2021-2026)
  4. 10.2.2 China Bioconjugation Service Revenue by Type (2027-2032)
  5. 10.3 China Bioconjugation Service Revenue Share by Type (2021-2032)
  6. 10.4 China Bioconjugation Service Revenue by Application (2021-2032)
  7. 10.4.1 China Bioconjugation Service Revenue by Application (2021-2026)
  8. 10.4.2 China Bioconjugation Service Revenue by Application (2027-2032)
  9. 10.5 China Bioconjugation Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bioconjugation Service Revenue (2021-2032)
  2. 11.2 Asia Bioconjugation Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bioconjugation Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bioconjugation Service Revenue by Type (2027-2032)
  5. 11.3 Asia Bioconjugation Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bioconjugation Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bioconjugation Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bioconjugation Service Revenue by Application (2027-2032)
  9. 11.5 Asia Bioconjugation Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bioconjugation Service Revenue by Country
  11. 11.6.1 Asia Bioconjugation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bioconjugation Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bioconjugation Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bioconjugation Service Revenue (2021-2032)
  2. 12.2 SAMEA Bioconjugation Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bioconjugation Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bioconjugation Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bioconjugation Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bioconjugation Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bioconjugation Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bioconjugation Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bioconjugation Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bioconjugation Service Revenue by Country
  11. 12.6.1 SAMEA Bioconjugation Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bioconjugation Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bioconjugation Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst